Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis
- 1. Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN (United States)
- 2. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (United States)
- 3. Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York (United States)
- 4. Division of Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York (United States)
Description
Background & aims: Cytochrome P450 2A5 (CYP2A5) is induced by ethanol, and the ethanol induction of CYP2A5 is regulated by nuclear factor-erythroid 2-related factor 2 (NRF2). Cyp2a5 knockout (Cyp2a5−/−) mice develop more severe alcoholic fatty liver than Cyp2a5+/+ mice. Fibroblast growth factor 21 (FGF21), a PPARα-regulated liver hormone, is involved in hepatic lipid metabolism. Alcoholic and non-alcoholic fatty liver are enhanced in Pparα knockout (Pparα−/−) mice. This study investigates the relationship between the PPARα-FGF21 axis and the enhanced alcoholic fatty liver in Cyp2a5−/− mice. Methods: Mice were fed the Lieber-Decarli ethanol diet to induce alcoholic fatty liver. Results: More severe alcoholic fatty liver disease was developed in Cyp2a5−/− mice than in Cyp2a5+/+ mice. Basal FGF21 levels were higher in Cyp2a5−/− mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5−/− mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice. Basal levels of serum FGF21 were lower in Pparα−/− mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα−/− mice, whereas ethanol induced hypertriglyceridemia in Pparα−/− mice but not in Pparα+/+ mice. Administration of recombinant FGF21 normalized serum FGF21 and triglyceride in Pparα−/− mice. Alcoholic fatty liver was enhanced in liver-specific Fgf21 knockout mice. Pparα and Cyp2a5 double knockout (Pparα−/−/Cyp2a5−/−) mice developed more severe alcoholic fatty liver than Pparα+/+/Cyp2a5−/− mice. Conclusions: These results suggest that CYP2A5 protects against the development of alcoholic fatty liver disease, and the PPARα-FGF21 axis contributes to the protective effects of CYP2A5 on alcoholic fatty liver disease.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.tox.2017.01.016Additional details
Identifiers
- DOI
- 10.1016/j.tox.2017.01.016;
- PII
- S0300-483X(17)30025-2;
Publishing Information
- Journal Title
- Toxicology
- Journal Volume
- 379
- Journal Page Range
- p. 12-21
- ISSN
- 0300-483X
- CODEN
- TXCYAC
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49039668
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- COUMARIN; CYTOCHROMES; ELECTROPHORESIS; EOSIN; ETHANOL; FIBROBLASTS; GELS; GROWTH FACTORS; HEMATOXYLIN; HYDROXYLASES; INSULIN; KNOCK-OUT REACTIONS; LIVER; METABOLISM; MICE; PHOSPHOTRANSFERASES; POTASSIUM; POTASSIUM CHLORIDES; RECEPTORS; SODIUM; SUBSTRATES; SULFATES; TRIGLYCERIDES
- Descriptors DEC
- ALCOHOLS; ALKALI METAL COMPOUNDS; ALKALI METALS; ANIMAL CELLS; ANIMALS; ANTICOAGULANTS; AROMATICS; BODY; CARBOXYLIC ACIDS; CHLORIDES; CHLORINE COMPOUNDS; COLLOIDS; CONNECTIVE TISSUE CELLS; DIGESTIVE SYSTEM; DIRECT REACTIONS; DISPERSIONS; DRUGS; DYES; ELEMENTS; ENZYMES; ESTERS; GLANDS; HALIDES; HALOGEN COMPOUNDS; HEMATOLOGIC AGENTS; HETEROCYCLIC COMPOUNDS; HETEROCYCLIC OXYGEN COMPOUNDS; HORMONES; HYDROCARBONS; HYDROXY ACIDS; HYDROXY COMPOUNDS; INDICATORS; LACTONES; LIPIDS; MAMMALS; MEMBRANE PROTEINS; METALS; MITOGENS; NUCLEAR REACTIONS; ORGANIC ACIDS; ORGANIC BROMINE COMPOUNDS; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; ORGANS; OXIDOREDUCTASES; OXYGEN COMPOUNDS; PEPTIDE HORMONES; PHENOLS; PHOSPHORUS-GROUP TRANSFERASES; PIGMENTS; POLYPHENOLS; POTASSIUM COMPOUNDS; POTASSIUM HALIDES; PROTEINS; PYRANS; RODENTS; SOMATIC CELLS; SULFUR COMPOUNDS; TRANSFERASES; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.